← Back to Search

Proteomic Profiling for Diagnosing Ovarian Cancer

N/A

Waitlist Available

Research Sponsored by Gynecologic Oncology Group

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Abnormal pelvic mass by physical examination or imaging test

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is studying how well a protein test works in diagnosing ovarian cancer.

Who is the study for?

This trial is for individuals with an abnormal pelvic mass that hasn't been diagnosed yet. They're planning to have surgery within the next three weeks to evaluate this mass and must not be pregnant as confirmed by a negative pregnancy test.Check my eligibility

What is being tested?

The study is looking at how well proteomic profiling (a method of analyzing proteins in the blood) can diagnose ovarian cancer in patients who are about to undergo surgery for an abnormal pelvic mass.See study design

What are the potential side effects?

Since this trial involves diagnostic testing rather than treatment, there are no direct side effects from medications or interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have an abnormal growth in my pelvic area found by a doctor or through imaging.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proteomic proflie (i.e. discrimination of tumor from nontumor in pelvic mass)

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Gynecologic Oncology GroupLead Sponsor

250 Previous Clinical Trials

68,926 Total Patients Enrolled

49 Trials studying Ovarian Cancer

5,847 Patients Enrolled for Ovarian Cancer

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,931,153 Total Patients Enrolled

285 Trials studying Ovarian Cancer

71,766 Patients Enrolled for Ovarian Cancer

Samir N. Khleif, MDNational Cancer Institute (NCI)

7 Previous Clinical Trials

125 Total Patients Enrolled

2 Trials studying Ovarian Cancer

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT00238342 — N/A

Ovarian Cancer Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT00238342 — N/A

Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT00238342 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still positions available for subjects of this research?

"On clinicaltrials.gov, this medical trial is listed as inactive; its original posting was posted on October 1st 2005 and the last update occurred 6th February 2010. Nevertheless, there are still 691 other investigations seeking participants at present."

Answered by AI

Are there numerous sites in the US participating in this experimental trial?

"This clinical trial can be accessed at several locations, such as the George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus in New Britain, Connecticut; Van Elslander Cancer Center at St. John Hospital and Medical Center in Grosse Pointe Woods, Michigan; Saint Louis University Cancer Centre in Saint Louis, Missouri; among other medical centres."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

2005. "Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00238342.

All > Fallopian Tube Cancer